These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3135740)

  • 21. Clinical trials and decisions for thrombolytic therapy in patients with acute myocardial infarction.
    Conti CR
    Clin Cardiol; 1990 May; 13(5):307-8. PubMed ID: 2112073
    [No Abstract]   [Full Text] [Related]  

  • 22. From swirling to a mobile, pedunculated mass--the evolution of left ventricular thrombus despite full anticoagulation. Echocardiographic demonstration.
    Glikson M; Agranat O; Ziskind Z; Kaplinski E; Vered Z
    Chest; 1993 Jan; 103(1):281-3. PubMed ID: 8417899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular thrombosis and arterial embolism after thrombolysis in acute anterior myocardial infarction: predictors and effects of adjunctive antithrombotic therapy.
    Kontny F; Dale J; Hegrenaes L; Lem P; Søberg T; Morstøl T
    Eur Heart J; 1993 Nov; 14(11):1489-92. PubMed ID: 8299630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic embolization following thrombolytic therapy for acute myocardial infarction.
    Zahger D; Weiss AT; Anner H; Waksman R
    Chest; 1990 Mar; 97(3):754-6. PubMed ID: 2306981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
    Bassand JP
    Eur Heart J; 1994 Jan; 15(1):2-4. PubMed ID: 8174579
    [No Abstract]   [Full Text] [Related]  

  • 27. Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups.
    Lorenzoni R; Pagano D; Mazzotta G; Rosen SD; Fattore G; De Caterina R; Gensini G
    Eur Heart J; 1998 Oct; 19(10):1518-24. PubMed ID: 9820990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular mural thrombus and the risk of embolic stroke after acute myocardial infarction.
    Vaitkus PT
    J Cardiovasc Risk; 1995 Apr; 2(2):103-6. PubMed ID: 7606646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myocardial infarction: is streptokinase really as effective as tissue plasminogen activator?
    Vine DL
    Kans Med; 1990 May; 91(5):147-8. PubMed ID: 2115093
    [No Abstract]   [Full Text] [Related]  

  • 30. The prevention of left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.
    Zatuchni J
    Angiology; 1989 Dec; 40(12):1085. PubMed ID: 2596744
    [No Abstract]   [Full Text] [Related]  

  • 31. Tissue-type plasminogen activator for acute coronary thrombosis.
    Med Lett Drugs Ther; 1987 Dec; 29(754):107-9. PubMed ID: 3119965
    [No Abstract]   [Full Text] [Related]  

  • 32. What you should know about thrombolytic therapy for acute MI.
    Aragon D; Martin M
    Am J Nurs; 1993 Sep; 93(9):24-31; quiz 33. PubMed ID: 8213959
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravenous administration of a thrombolytic agent is the only realistic therapeutic approach in evolving myocardial infarction.
    Verstraete M
    Eur Heart J; 1985 Jul; 6(7):586-93. PubMed ID: 3930247
    [No Abstract]   [Full Text] [Related]  

  • 34. [Coronary thrombolysis in patients with acute myocardial infarction].
    Kambara H; Fudo T; Ono S
    Kokyu To Junkan; 1992 Jun; 40(6):537-47. PubMed ID: 1620990
    [No Abstract]   [Full Text] [Related]  

  • 35. The GUSTO trial: is the open-artery hypothesis proven?
    Stringer KA; Lindenfeld J
    Ann Pharmacother; 1994 Jan; 28(1):97-8. PubMed ID: 8123971
    [No Abstract]   [Full Text] [Related]  

  • 36. Stroke in patients treated with thrombolytic therapy for acute myocardial infarction. The thrombosis in myocardial infarction clinical trial and a review of placebo-controlled trials.
    Price TR
    Stroke; 1990 Nov; 21(11 Suppl):III8-9. PubMed ID: 2122557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
    Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
    Iakovlev VB; Gospodarenko AL; Makarenko AS
    Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.